EUVIMEDEUVIMED entdecken
Open Access

Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention

Howard Hong iD, Usman Aslam-Mir, Richard Kajubi, Erika Wallender iD, Norah Mwebaza, Grant Dorsey, Philip J Rosenthal iD, Francesca T Aweeka, Liusheng Huang iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01427-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Howard Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Unit, Department of Clinical Pharmacy, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Quinolines, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydroartemisinin-piperaquine (DP) is highly effective for malaria chemoprevention during pregnancy, but the standard dosing of DP that is used for nonpregnant adults may not be optimal for pregnant women. We previously reported that the pharmacokinetic exposure of total piperaquine (PQ; both bound and unbound to plasma proteins) is reduced significantly in the context of pregnancy or efavirenz (EFV)-based antiretroviral therapy (ART).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaQuinolinesHIV InfectionsAdultPregnancyHumansFemaleChemopreventionPiperazinesAlkynesCyclopropanesBenzoxazinesArtemisinins

Stichwörter der Autor:innen

drug-drug interactionefavirenzmalariapregnancyultrafiltrationunbound piperaquine

Substanzen

AntimalarialsQuinolinespiperaquinePiperazinesefavirenzAlkynesCyclopropanesBenzoxazinesartenimolArtemisinins

Autor:innen und Institutionen

  • Drug Research Unit, Department of Clinical Pharmacy, University of California, San Francisco, California, USA.
  • Infectious Disease Research Collaboration, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Medicine, University of California, San Francisco, California, USA.

ORCID-Profile: Howard Hong, Erika Wallender, Philip J Rosenthal, Liusheng Huang

Förderung

  • NICHD NIH HHS
  • NIAID NIH HHS
  • NCATS NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Hong, H., Aslam-Mir, U., Kajubi, R., Wallender, E., Mwebaza, N., Dorsey, G., Rosenthal, P. J., Aweeka, F. T., & Huang, L. (2023). Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01427-22

Vancouver

Hong H, Aslam-Mir U, Kajubi R, Wallender E, Mwebaza N, Dorsey G, et al. Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01427-22

BibTeX
@article{Hong2023,
  author = {Hong, Howard and Aslam-Mir, Usman and Kajubi, Richard and Wallender, Erika and Mwebaza, Norah and Dorsey, Grant and Rosenthal, Philip J and Aweeka, Francesca T and Huang, Liusheng},
  title = {Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01427-22}
}
Kostenlos starten →